Richo and Jones interviews Clive Palmer; thanks him for his generous hydroxychloroquine donation to the nation
Watch the video“Clive, we’re very grateful.” In an interview with Clive Palmer, Alan Jones teases
29/04/2020 9:11 pm
Latest News
Global
C19study.com update: Now 118 international studies (71 peer reviewed) show positive hydroxychloroquine treatment outcomes
Source: C19Study A live and ongoing index of studies from around the world documenting the use
28/09/2020
Azithromycin
Italy study: A new look at safety with hydroxychloroquine in COVID-19
In our study, we found hydroxychloroquine wasn’t associated with significant arrhythmia clearly relating to hydroxychloroquine so it seemed the drug was very, very safe
28/09/2020
Azithromycin
Lancet: “Overall mortality was lower in the hydroxychloroquine group”. Study, Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
Source: The Lancet Summary Background Hydroxychloroquine is one of several agents being evaluated in the
21/09/2020
Azithromycin
University of Minnesota study: “No deaths occurred related to hydroxychloroquine. ” Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
In this trial, no deaths occurred related to hydroxychloroquine, and serious side effects were rare.
21/09/2020
Chloroquine
HYDROXYCHLOROQUINE AND THE BURDEN OF PROOF
An Urgent Call to Depoliticize Medicine in the COVID-19 Pandemic
20/09/2020
Azithromycin
Ghana: “HCQ and AZ associated with viral clearance in COVID-19 patients.” Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study
HCQ or CQ should be used efficiently alone or in combination with AZ to optimize the management of asymptomatic and mild cases of COVID-19.
15/09/2020
Hydroxychloroquine
COVID-19 is a lack of nutrients, exploited by a virus
Source: Primary Doctor Author: Colleen Huber, NMD Abstract COVID-19 disease is alleged to be caused
07/09/2020
Clinical Trials
Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization: A Systematic Review
Source: Research Gate Conclusions Hydroxychloroquine has been shown to have consistent clinical efficacy for COVID-19
04/09/2020
Belgium
A simple and clear explanation of recent positive and negative studies: hydroxychloroquine has strong evidence of efficacy, by Dr John Campbell
Dr. John Campbell Belgium, not Dutch. Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with
28/08/2020
Hydroxychloroquine
New Jersey Study of 1,274: Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19; A multi-center observational study where hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization
In this study, SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization.
25/08/2020
Azithromycin
Italy Study 3,451 patients: Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
HCQ use was associated with a 30% lower risk of death in COVID-19 hospitalized patients. Our data doesn’t discourage use of HCQ in inpatients with COVID-19.
25/08/2020
Belgium
Belgium Study: Low-dose Hydroxychloroquine Therapy and Mortality (Lowered) in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
Source: Science Direct Authors: LucyCatteauPharmD, PhDafi#NicolasDaubyMD, PhDbcdfi#MarionMontourcyMScafiEmmanuelBottieauMD, PhDefiJorisHautekietMScagfiElsGoetghebeurPhDfigSabrinavan IersselMD, PhDfihElsDuysburghMD, MPH, PhDafiHermanVan OyenMD, DrPHafhiChloéWyndham-ThomasMD, PhDafiDominiqueVan
24/08/2020
Australia
Australia: Clinical trial looks to protect high-risk healthcare workers against COVID-19 using hydroxychloroquine as preventative to corona
Source: St Vincent’s Hospital Melbourne Healthcare workers are part of the first line of defence
21/08/2020
Azithromycin
Mortality 0%: A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island
Indeed, following bivariate analysis, hydroxychloroquine/azithromycin treatment was associated with a lower rate of ICU admission (P=0.008).
20/08/2020
Hydroxychloroquine
Possible role of ABCB1 in lysosomal accumulation of azithromycin in COVID-19 therapy
Source: PubMed. Author: Jean-Michel Scherrmann Scherrmann JM. Possible role of ABCB1 in lysosomal accumulation of
17/08/2020
Hydroxychloroquine
Pandemic: National Town Hall, The Case for Hydroxy Pt.1 (w/ Dr. Harvey Risch, Dr. Vladimir Zelenko, and Dr. Li Meng Yan)
Source: Pandemic War room Jack Maxey and Vish Burra bring you a special edition of
09/08/2020
Censorship
Henry Ford Health Defends Study, Shows Hydroxychloroquine Does Reduce Death Rates
Source: CBS Detroit (CBS DETROIT) – Henry Ford Health System is defending its hydroxychloroquine study showing
04/08/2020
China
China Study of 2882 patients: Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs
HCQ treatment can reduce systemic inflammation and inhibit the cytokine storm, thus protecting multiple organs from inflammatory injuries.
03/08/2020
Hydroxychloroquine
Italian Study: Hydroxychloroquine Cut Death Risk 66 Percent
Source: Newsmax An Italian study found that hospitalized coronavirus patients who took anti-malaria drug hydroxychloroquine combined
02/08/2020
Azithromycin
France Study: Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time
Indeed, our study suggests that AZI±HCQ might have impacted COVID-19 outcome in a population of patients, optimal timing of treatment interventions to study
02/08/2020
Hydroxychloroquine
Italy Study: Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation? – 66% reduction in risk of death
hydroxycholoroquine + azithromycin was associated with a 66% reduction in risk of death as compared to controls; the analysis also suggested a larger effectiveness of hydroxychloroquine in patients with less severe COVID-19 disease
29/07/2020
Clinical Trials
61 studies (37 peer reviewed) Early treatment studies are very positive – COVID deaths: 621, 206
Source: c19study.com The studies continue to roll out, and there has been very positive results
23/07/2020
Official
Madrid Study: Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid – Risk of death significantly lower with HCQ
Source: Medrxiv.org In this analysis of 1645 patients hospitalized with COVID-19 we find that the
17/07/2020
Medical Study
South Korea Study: Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
Source: IC Journal Citation: Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee
16/07/2020
Hydroxychloroquine
UK Study: Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls
HCQ use significantly reduced the mortality rate, but this association was found only in the lowest cumulative dosage exposure group.
12/07/2020
Azithromycin
Zelenko study: COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin; A Retrospective Case Series Study
Source: preprints.org Scholz, M.; Derwand, R.; Zelenko, V. COVID-19 Outpatients – Early Risk-Stratified Treatment with
04/07/2020
Azithromycin
HENRY FORD STUDY: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
Source: International Journal of Infectious Diseases Highlights As of May27, 2020 there are over 1,678,843
01/07/2020
Hydroxychloroquine
NY Study: Risk Factors for Mortality in Patients with COVID-19 in New York City
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
30/06/2020
France
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/ azithromycin and other regimens in Marseille, France: A retrospective analysis
Source: Science Direct Background In our institute in Marseille, France, we initiated early and massive
25/06/2020
Chloroquine
COVID-19: Nigerian study finds Chloroquine, Hydroxychloroquine effective as Prophylaxis
Source: Vanguard Nigeria Preliminary trials on the use of chloroquine and hydroxychloroquine as prophylaxis for
23/06/2020
China
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19 Spike pseudotype virus
Source: BioRxiv The pandemic coronavirus COVID-19 affected global health from the end of 2019 to
22/06/2020
China
Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
22/06/2020
Chloroquine
Denmark: Chloroquine, but not hydroxychloroquine, prolongs the QT interval in a primary care population
Conclusions: In subjects free of COVID-19, we found a small increase in QTc associated with use of chloroquine, but not hydroxychloroquine. We found no increased mortality associated with use of hydroxychloroquine.
22/06/2020
Chloroquine
Study|China- Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
22/06/2020
Clinical Trials
Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
19/06/2020
Azithromycin
Spain Study: A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications.
None of the patients died in the studied period and only 6 have to be admitted in conventional hospitalization area.
12/06/2020
Hydroxychloroquine
Study: Strategy – HCQ + AZ treats mild COVID-19 to reduce hospital admissions and complications.
Source: MedRxiv Abstract: The new SARS-CoV-2 infection named COVID-19 has severely hit our Health System.
12/06/2020
Hydroxychloroquine
12/06/2020
France
Study – Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world (19,270 patients – is effective)
Source: ScienceDirect | PDF of full Journal Pre-Print Abstract In the context of the current
06/06/2020
Global
Lancet RETRACTS suspect research study of 96,000, which stated HCQ had no effect. Important win for science.
Preface: On May 22, The Lancet published a study of 96,000 COVID-19 patients stating Hydroxychloroquine
05/06/2020
Clinical Trials
EARLY DIAGNOSIS AND MANAGEMENT OF COVID-19 PATIENTS: A REAL-LIFE COHORT STUDY OF 3,737 PATIENTS, MARSEILLE, FRANCE (HCQ-AZ)
Source: Mediterranee Infection COVID-IHU #15 Version 1 du 27 Mai 2020Early diagnosis and management of COVID-19 patients: a real-life cohort study of 3,737 patients,
28/05/2020
Australia
182 Professionals from 25 countries around the globe raise serious concerns with The Lancet’s anti HCQ report
Source: Zendo In an open letter to MR Mehra, SS Desai, F Ruschitzka, and AN
28/05/2020
Clinical Trials
YALE: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis (HCQ – AZ)
Source: Oxford Academic – American Journal of Endimology Original unedited manuscript as PDF Abstract More
28/05/2020
Hydroxychloroquine
World renowned Dr leading one of the largest U.S. studies sees hydroxychloroquine promise
Source: FOX 2 – Detroit The FDA has warned against taking hydroxychloroquine, but President Trump says
21/05/2020
Hydroxychloroquine
Adding Zinc to hydroxychloroquine and azithromycin improves odds: 44% less likely to die from COVID-19 (NYU Study of 900).
Source: NY1 NEW YORK – Researchers at NYU’s Grossman School of Medicine found patients given
17/05/2020
Clinical Trials
Peer reviewed; 91.7% good outcomes with early treatment of COVID-19 patients using hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Source: Science Direct Abstract Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is
08/05/2020
China
China study of 568 critically ill Covid-19 patients: Hydroxychloroquine treatment significantly associated with a decreased mortality, through attenuation of inflammatory cytokine storm.
Source: MedRxiv Abstract Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs
01/05/2020
Hydroxychloroquine
DRUG TRIAL 2,300 patients; physicians and surgeons (AAPS) say hydroxychloroquine drug DOES help 91% of coronavirus patients
SOURCE: The Sun UKDOCTORS in the US have claimed that a now controversial malaria drug
29/04/2020
Azithromycin
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Source: Science Direct PhilippeGautretab1Jean-ChristopheLagierac1PhilippeParolaabVan ThuanHoangabdLineMeddebaJacquesSevestreaMorganeMailheaBarbaraDoudieraCamilleAubryaSophieAmraneaPisethSengaMarieHocquartaCaroleEldinabJulieFinanceeVera EstevesVieiraaHervé TissotTissot-DupontacStéphaneHonoréfgAndreasSteinacMatthieuMillionacPhilippeColsonacBernardLa ScolaacVéroniqueVeithAlexisJacquieriJean-ClaudeDeharojMichelDrancourtacPierre EdouardFournierabJean-MarcRolainacPhilippeBrouquiacDidierRaoultac aIHU-Méditerranée Infection, Marseille, France bAix Marseille
11/04/2020
Hydroxychloroquine
Dr. Vladimir Zelenko: Hydroxychloroquine, Zinc Sulfate and Azithromycin are showing excellent results with 900 coronavirus patients treated.
Source: Tech Startups Peak Prosperity April 8 Update: More doctors are now saying Hydroxychloroquine only works
08/04/2020
Australia
INFO ALERT: In Australia the ban on hydroxychloroquine is criminal.
The health bureaucrats have violated the first principle of the Hippocratic Oath , which is to do no harm.
27/09/2020
Australia
‘Criminal’ ban on hydroxychloroquine based on ‘faulty’ study
Source: Sky News Liberal MP Craig Kelly says the ban placed on COVID-19 treatment hydroxychloroquine
27/09/2020
A Patient Story
Antwerp Rotary Learn About Hydroxychloroquine
Source: The West Bend News The Antwerp Rotary Club met on Thursday, September 17 at
26/09/2020
Azithromycin
Therapeutic Management of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Treatment Algorithm
In the first phase of the pandemic, 81% of deaths were in elderly homes. 50% of those deaths due to COVID-19 in nursing homes were avoidable with HCQ.
26/09/2020
Hydroxychloroquine
Hydroxychloroquine seems to be safe for COVID-19 patients, report researchers focused on arrhythmic safety
Hydroxychloroquine seems to be safe, regardless of the clinical setting in which it is started, so long as an adequate ECG monitoring strategy is in place.
25/09/2020
Azithromycin
How the U.S. President actually came to embrace hydroxychloroquine
HCQ, combined with zinc, is a very effective treatment for COVID-19, especially if administered very soon after infection.
25/09/2020
France
Morocco Covid-19: Hydroxychloroquine soon on sale in pharmacies
Hydroxychloroquine will now be on sale in pharmaceutical pharmacies in france, as part of the treatment for COVID-19
24/09/2020
About The Foundation
The Palmer Foundation is the philanthropic entity owned by the Palmer family, headed by Clive Palmer.
The Palmer Foundation is a private entity that engages in charitable projects that enable better welfare of others, and society as a whole.
The foundations most recent endeavour revolves around the response to, and action on the COVID-19 Virus pandemic for the treatment of all Australians in need.
Click here to get the background on The Palmer Foundations COVID-19 Response.
Share on facebook
Share on twitter
Share on whatsapp
On Trend
Popular Stories
Global
C19study.com update: Now 118 international studies (71 peer reviewed) show positive hydroxychloroquine treatment outcomes
Source: C19Study A live and ongoing index of studies from around the world documenting the use
28/09/2020
Azithromycin
Italy study: A new look at safety with hydroxychloroquine in COVID-19
In our study, we found hydroxychloroquine wasn’t associated with significant arrhythmia clearly relating to hydroxychloroquine so it seemed the drug was very, very safe
28/09/2020
Australia
INFO ALERT: In Australia the ban on hydroxychloroquine is criminal.
The health bureaucrats have violated the first principle of the Hippocratic Oath , which is to do no harm.
27/09/2020
Australia
‘Criminal’ ban on hydroxychloroquine based on ‘faulty’ study
Source: Sky News Liberal MP Craig Kelly says the ban placed on COVID-19 treatment hydroxychloroquine
27/09/2020